Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntington's disease.

Huntington's disease (HD) is an inherited neurodegenerative disorder caused by abnormal expansion of glutamine repeats in the protein huntingtin. In HD brain, mutant huntingtin undergoes proteolytic processing, and its N-terminal fragment containing poly-glutamine repeats accumulate as insoluble aggregates leading to the defect in cellular protein quality control system and heat shock response (HSR). Here we demonstrate that the defective HSR in the brain is due to the down-regulation of heat shock factor 1 (HSF1) in both mice and fly models of HD. Interestingly, treatment of dexamethasone (a synthetic glucocorticoid) to HD mice or flies significantly increased the expression and transactivation of HSF1 and induction of HSR and these effects are mediated through the down-regulation of HSP90. Dexamethasone treatment also significantly decreased the aggregate load and transient recovery of HD-related behavioural phenotypes in both disease models. These results suggest that dexamethasone could be a potential therapeutic molecule for the treatment of HD and related poly-glutamine disorders.

[1]  R. Mukherjee,et al.  Dysfunction of the Ubiquitin Ligase Ube3a May Be Associated with Synaptic Pathophysiology in a Mouse Model of Huntington Disease* , 2012, The Journal of Biological Chemistry.

[2]  Martin L. Duennwald,et al.  Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin , 2012, PloS one.

[3]  R. Paro,et al.  Hsp90 Globally Targets Paused RNA Polymerase to Regulate Gene Expression in Response to Environmental Stimuli , 2012, Cell.

[4]  G. Bates,et al.  Suppression of protein aggregation by chaperone modification of high molecular weight complexes , 2012, Brain : a journal of neurology.

[5]  Lin Du,et al.  Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets , 2011, Nature Medicine.

[6]  G. Bates,et al.  Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. , 2011, The Journal of clinical investigation.

[7]  L. Sistonen,et al.  Regulation of HSF1 function in the heat stress response: implications in aging and disease. , 2011, Annual review of biochemistry.

[8]  S. Shankar,et al.  Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin. , 2010, Human molecular genetics.

[9]  A. Nakai,et al.  Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT , 2010, The EMBO journal.

[10]  D. Thiele,et al.  Modulation of Heat Shock Transcription Factor 1 as a Therapeutic Target for Small Molecule Intervention in Neurodegenerative Disease , 2010, PLoS biology.

[11]  N. Nukina,et al.  Induction of chemokines, MCP‐1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction , 2009, Journal of neurochemistry.

[12]  M. Yamaguchi,et al.  Heat Shock Transcription Factor 1-activating Compounds Suppress Polyglutamine-induced Neurodegeneration through Induction of Multiple Molecular Chaperones* , 2008, Journal of Biological Chemistry.

[13]  A. Messer,et al.  Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Amit Mishra,et al.  E6-AP Promotes Misfolded Polyglutamine Proteins for Proteasomal Degradation and Suppresses Polyglutamine Protein Aggregation and Toxicity* , 2008, Journal of Biological Chemistry.

[15]  N. Nukina,et al.  Mutant Huntingtin reduces HSP70 expression through the sequestration of NF‐Y transcription factor , 2008, The EMBO journal.

[16]  J. Min,et al.  Demyelination, Astrogliosis, and Accumulation of Ubiquitinated Proteins, Hallmarks of CNS Disease in hsf1-Deficient Mice , 2007, The Journal of Neuroscience.

[17]  H. Zoghbi,et al.  Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.

[18]  J. Uney,et al.  Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  S. Tabrizi,et al.  Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. , 2007, Human molecular genetics.

[20]  Harry T Orr,et al.  Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. , 2006, Genes & development.

[21]  Y. Kitaura,et al.  Active HSF1 Significantly Suppresses Polyglutamine Aggregate Formation in Cellular and Mouse Models* , 2005, Journal of Biological Chemistry.

[22]  Steven M Hersch,et al.  Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice , 2005, The Journal of comparative neurology.

[23]  Huda Y. Zoghbi,et al.  Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles , 2005, Nature Reviews Genetics.

[24]  Keiji Tanaka,et al.  Co-chaperone CHIP Associates with Expanded Polyglutamine Protein and Promotes Their Degradation by Proteasomes* , 2005, Journal of Biological Chemistry.

[25]  S. Westerheide,et al.  Celastrols as Inducers of the Heat Shock Response and Cytoprotection*[boxs] , 2004, Journal of Biological Chemistry.

[26]  G. Bates,et al.  Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. , 2004, Human molecular genetics.

[27]  R. Morimoto,et al.  Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. , 2003, Molecular biology of the cell.

[28]  A. Morton,et al.  Microglia density decreases with age in a mouse model of Huntington's disease , 2003, Glia.

[29]  E. Simpson,et al.  Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. , 2003, Human molecular genetics.

[30]  Cynthia Kenyon,et al.  Regulation of Aging and Age-Related Disease by DAF-16 and Heat-Shock Factor , 2003, Science.

[31]  Marcel Leist,et al.  Overexpression of heat shock protein 70 in R6/2 Huntington’s disease mice has only modest effects on disease progression , 2003, Brain Research.

[32]  D. Rubinsztein,et al.  Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. , 2002, Human molecular genetics.

[33]  R. Hosono,et al.  Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot‐2 (mortalin)/mthsp70/Grp75 , 2002, FEBS letters.

[34]  H. Kampinga,et al.  Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. , 2002, Human molecular genetics.

[35]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[36]  R. Morimoto,et al.  Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1 , 2001, The EMBO journal.

[37]  H. Lehrach,et al.  Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. , 2001, Human molecular genetics.

[38]  P G Bhide,et al.  Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain , 2001, Journal of neuropathology and experimental neurology.

[39]  H. Paulson,et al.  Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. , 2000, Human molecular genetics.

[40]  N. Nukina,et al.  Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. , 2000, Human molecular genetics.

[41]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. W. Davies,et al.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Kirchhoff,et al.  Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. , 2000, American journal of physiology. Heart and circulatory physiology.

[44]  G. Sobue,et al.  Chaperones Hsp70 and Hsp40 Suppress Aggregate Formation and Apoptosis in Cultured Neuronal Cells Expressing Truncated Androgen Receptor Protein with Expanded Polyglutamine Tract* , 2000, The Journal of Biological Chemistry.

[45]  S. Benzer,et al.  Genetic suppression of polyglutamine toxicity in Drosophila. , 2000, Science.

[46]  H. Paulson,et al.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.

[47]  H. Paulson,et al.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.

[48]  Iris Salecker,et al.  Polyglutamine-Expanded Human Huntingtin Transgenes Induce Degeneration of Drosophila Photoreceptor Neurons , 1998, Neuron.

[49]  R. Voellmy,et al.  Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1 , 1998, Cell.

[50]  Marian DiFiglia,et al.  Huntington Disease , 1998, Journal of neuropathology and experimental neurology.

[51]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[52]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[53]  R. Snell,et al.  Neuropathological diagnosis and CAG repeat expansion in Huntington's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[54]  S. Folstein,et al.  Early Loss of Neostriatal Striosome Neurons in Huntington's Disease , 1995, Journal of neuropathology and experimental neurology.

[55]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[56]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[57]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[58]  A. Knowlton,et al.  Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. , 2001, American journal of physiology. Heart and circulatory physiology.

[59]  Michael A. Mancini,et al.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 , 1998, Nature Genetics.

[60]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[61]  O. Onodera,et al.  Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.